JP2019515643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019515643A5 JP2019515643A5 JP2018515676A JP2018515676A JP2019515643A5 JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5 JP 2018515676 A JP2018515676 A JP 2018515676A JP 2018515676 A JP2018515676 A JP 2018515676A JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- cycloalkyl
- substituted
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021042947A JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222713P | 2015-09-23 | 2015-09-23 | |
| US62/222,713 | 2015-09-23 | ||
| PCT/US2016/053571 WO2017053886A2 (en) | 2015-09-23 | 2016-09-23 | Method of screening for agents for differentiating stem cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021042947A Division JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019515643A JP2019515643A (ja) | 2019-06-13 |
| JP2019515643A5 true JP2019515643A5 (enExample) | 2019-11-07 |
Family
ID=58387520
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515676A Pending JP2019515643A (ja) | 2015-09-23 | 2016-09-23 | 幹細胞分化剤のスクリーニング方法 |
| JP2021042947A Active JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021042947A Active JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11931347B2 (enExample) |
| EP (1) | EP3352566A4 (enExample) |
| JP (2) | JP2019515643A (enExample) |
| CN (2) | CN113527289A (enExample) |
| AU (2) | AU2016326718B2 (enExample) |
| CA (1) | CA2999503A1 (enExample) |
| IL (3) | IL258314B (enExample) |
| WO (1) | WO2017053886A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019515643A (ja) | 2015-09-23 | 2019-06-13 | ミネルバ バイオテクノロジーズ コーポレーション | 幹細胞分化剤のスクリーニング方法 |
| WO2018064465A1 (en) | 2016-09-29 | 2018-04-05 | The Regents Of The University Of California | Compounds for increasing neural plasticity |
| EP3600451B1 (en) * | 2017-03-29 | 2025-12-24 | Minerva Biotechnologies Corporation | Agents for differentiating stem cells and treating cancer |
| CN107892690A (zh) * | 2017-11-30 | 2018-04-10 | 江苏杏睿生物科技有限公司 | Fascaplysin的衍生物及制备方法与用途 |
| US20210299109A1 (en) * | 2017-12-19 | 2021-09-30 | Minerva Biotechnologies Corporation | Agents for treating cancer and methods for identifying said agents |
| CN107880040A (zh) * | 2017-12-22 | 2018-04-06 | 中国药科大学 | 一种四氢β－咔啉类衍生物及其制备方法与用途 |
| JP7770673B2 (ja) | 2019-02-27 | 2025-11-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 脳障害を治療するためのアゼピノ－インドール及び他の複素環化合物 |
| US12104170B2 (en) | 2020-06-26 | 2024-10-01 | Minerva Biotechnologies Corporation | Methods for deriving dopaminergic neurons from pluripotent stem cells |
| AU2021297535A1 (en) | 2020-06-26 | 2023-02-16 | Minerva Biotechnologies Corporation | Anti-NME antibody and method of treating cancer or cancer metastasis |
| AU2022416279A1 (en) | 2021-12-15 | 2024-07-25 | Delix Therapeutics, Inc. | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof |
| WO2023201234A2 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| CN115521306B (zh) * | 2022-09-26 | 2024-03-26 | 贵州大学 | 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用 |
| CN115594675B (zh) * | 2022-11-02 | 2024-01-30 | 西安医学院 | 一种 β-卡巴林-肉桂酸骨架衍生物及制备方法和用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| US7625697B2 (en) | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US20030099611A1 (en) * | 1995-09-01 | 2003-05-29 | Sara Lavi | Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection |
| PL329875A1 (en) | 1996-05-10 | 1999-04-12 | Icos Corp | Derivatives of carbolin |
| CA2517416A1 (en) * | 2003-02-28 | 2004-09-10 | Howard Florey Institute Of Experimental Physiology And Medicine | Therapeutic compositions |
| CN1852974A (zh) * | 2003-06-09 | 2006-10-25 | 密歇根大学董事会 | 用于治疗和诊断癌症的组合物和方法 |
| WO2004113300A1 (ja) | 2003-06-23 | 2004-12-29 | Ono Pharmaceutical Co., Ltd. | 新規三環性複素環化合物 |
| US7855295B2 (en) * | 2004-01-23 | 2010-12-21 | Novartis Vaccines And Diagnostics, Inc. | Tetrahydrocarboline compounds as anticancer agents |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| EA201200555A1 (ru) * | 2004-03-15 | 2013-01-30 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Производные карболина, полезные в ингибировании ангиогенеза |
| CA2584412C (en) * | 2004-09-14 | 2017-05-09 | Minerva Biotechnologies Corporation | Methods for diagnosis and treatment of cancer |
| ES2720288T3 (es) | 2005-03-30 | 2019-07-19 | Minerva Biotechnologies Corp | Proliferación de células que expresan MUC1 |
| WO2007076055A2 (en) * | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| AU2007317349B2 (en) * | 2006-11-03 | 2011-10-20 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| CN101652469B (zh) * | 2006-12-06 | 2014-04-16 | 米纳瓦生物技术公司 | 用于鉴定和操作细胞的方法 |
| WO2009022104A1 (en) * | 2007-08-13 | 2009-02-19 | De Montfort University | Fascaplysin derivatives and their use in the treatment of cancer |
| WO2009042815A1 (en) | 2007-09-25 | 2009-04-02 | Minerva Biotechnologies Corp. | Methods for treatment of cancer |
| EP2274617A4 (en) * | 2008-04-10 | 2011-11-09 | Massachusetts Inst Technology | METHOD OF DETECTING AND USING MEDIUM-TREATMENT AID ON CANCER STEM CELLS |
| WO2009140260A2 (en) | 2008-05-13 | 2009-11-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Cancer stem cell immortalization |
| EP3228629A1 (en) | 2010-06-16 | 2017-10-11 | Minerva Biotechnologies Corporation | Reprogramming cancer cells |
| JP2012068225A (ja) | 2010-08-25 | 2012-04-05 | Fujifilm Corp | 放射線画像撮影用グリッド及びその製造方法 |
| EP2561888A1 (en) | 2011-08-23 | 2013-02-27 | Deutsches Krebsforschungszentrum | Protein comprising NC-1 for treating angiogenesis-related diseases |
| WO2013059373A2 (en) * | 2011-10-17 | 2013-04-25 | Minerva Biotechnologies Corporation | Media for stem cell proliferation and induction |
| US20150224169A1 (en) | 2012-09-06 | 2015-08-13 | Mcmaster University | Compounds and methods for selectively targeting cancer stem cells |
| KR20210082547A (ko) * | 2013-02-20 | 2021-07-05 | 미네르바 바이오테크놀로지 코포레이션 | Ｎｍｅ 저해제 및 ｎｍｅ 저해제의 사용 방법 |
| AU2014306778B2 (en) | 2013-08-12 | 2020-10-29 | Minerva Biotechnologies Corporation | Method for enhancing tumor growth |
| CN103880841B (zh) | 2014-02-20 | 2016-04-13 | 南通大学 | 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途 |
| JP2019515643A (ja) | 2015-09-23 | 2019-06-13 | ミネルバ バイオテクノロジーズ コーポレーション | 幹細胞分化剤のスクリーニング方法 |
-
2016
- 2016-09-23 JP JP2018515676A patent/JP2019515643A/ja active Pending
- 2016-09-23 EP EP16849807.9A patent/EP3352566A4/en active Pending
- 2016-09-23 CA CA2999503A patent/CA2999503A1/en active Pending
- 2016-09-23 AU AU2016326718A patent/AU2016326718B2/en active Active
- 2016-09-23 US US15/762,897 patent/US11931347B2/en active Active
- 2016-09-23 CN CN202110344230.XA patent/CN113527289A/zh active Pending
- 2016-09-23 WO PCT/US2016/053571 patent/WO2017053886A2/en not_active Ceased
- 2016-09-23 CN CN201680064972.4A patent/CN108513537A/zh active Pending
-
2018
- 2018-03-22 IL IL258314A patent/IL258314B/en unknown
-
2021
- 2021-01-04 IL IL279941A patent/IL279941B/en unknown
- 2021-01-08 JP JP2021042947A patent/JP7138207B2/ja active Active
- 2021-10-25 IL IL287558A patent/IL287558B2/en unknown
-
2022
- 2022-11-21 AU AU2022275400A patent/AU2022275400B2/en active Active
-
2024
- 2024-01-19 US US18/418,112 patent/US20240307359A1/en not_active Abandoned